Jean-Claude Tardif

National Institutes of Health (NIH) helps fund ColCorona COVID-19 clinical study

Retrieved on: 
Tuesday, May 5, 2020
Health, Medicine, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Design of experiments, Breastfeeding, Jean-Claude Tardif, Data monitoring committee, Monitoring

Several sites in Canada, the United-States and Spain are participating in the clinical study.

Key Points: 
  • Several sites in Canada, the United-States and Spain are participating in the clinical study.
  • "The support of the National Heart, Lung, and Blood Institute comes at a critical time", said Dr. Jean-Claude Tardif.
  • Women who do not take contraceptives, those who are pregnant or those who are breastfeeding are not eligible for the clinical study.
  • The study will be monitored by a data monitoring committee (DMC) that includes experienced clinical researchers from the Montreal Health Innovations Coordinating Center (MHICC).

Vancouver Infectious Diseases Centre joins Montreal Heart Institute to evaluate potential treatment against COVID-19

Retrieved on: 
Wednesday, April 8, 2020
Montreal Heart Institute, Rosemont–La Petite-Patrie, MHI, Jean-Claude Tardif, Infectious disease, Health

MONTREAL and VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) Research Center today announced a strategic partnership with the Vancouver Infectious Diseases Centre (VIDC) in Vancouver, British Colombia, for its COVID-19 clinical study to evaluate whether colchicine will have an effect on reducing the rate of hospitalization of individuals recently diagnosed with COVID-19.

Key Points: 
  • MONTREAL and VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) Research Center today announced a strategic partnership with the Vancouver Infectious Diseases Centre (VIDC) in Vancouver, British Colombia, for its COVID-19 clinical study to evaluate whether colchicine will have an effect on reducing the rate of hospitalization of individuals recently diagnosed with COVID-19.
  • COLCORONA was initiated on March 23, 2020 at the Montreal Heart Institute in Canada by Dr. Jean-Claude Tardif, Director of the Research Center at MHI and Professor of Medicine at the University of Montreal.
  • The Montreal Health Innovations Coordinating Center (MHICC) is a leading academic clinical research organization and an integral part of the Montreal Heart Institute (MHI).
  • Vancouver Infectious Diseases Centre (VIDC) is a research and medical centre that delivers specialty healthcare and expert, state-of-the-art diagnosis, and treatment of chronic infectious diseases, with an emphasis on HCV and HIV.

Sophie Desmarais donates $1 million for research at the Montreal Heart Institute

Retrieved on: 
Friday, April 3, 2020
Jean-Claude Tardif, Montreal Heart Institute, Health, Montreal

MONTREAL, April 03, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute Foundation is proud to announce today that philanthropist Sophie Desmarais will be supporting the Montreal Heart Institutes research projects thanks to a $1 million donation that will be used by the Research Centre for their ColCorona study.

Key Points: 
  • MONTREAL, April 03, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute Foundation is proud to announce today that philanthropist Sophie Desmarais will be supporting the Montreal Heart Institutes research projects thanks to a $1 million donation that will be used by the Research Centre for their ColCorona study.
  • On March 23, the Institutes Research Centre launched this ground-breaking clinical study in order to help patients infected with COVID-19.
  • A heartfelt thank you to Sophie Desmarais who will allow us to deploy the resources necessary to support our research teams in these special circumstances, said Dr. Jean-Claude Tardif, Director of the Montreal Heart Institutes Research Centre.
  • We are privileged to be able to count on this kind-hearted philanthropist, added Alain Gignac, CEO of the Montreal Heart Institute Foundation.